Comparing Niacin vs Cymbalta
Niacin | Cymbalta (duloxetine) |
|
---|
Niacin | Cymbalta (duloxetine) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for High Cholesterol, Depression, Dietary Supplementation, Pellagra, Niacin Deficiency, Hyperlipoproteinemia, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V -... View more |
Prescription only
Cymbalta has antidepressant, anti-anxiety, and pain-relieving properties; however, it has been associated with a discontinuation syndrome on withdrawal even when tapered. Prescribed for Back Pain... View more |
Related suggestions Depression
|
|||||||
More about Niacin | More about Cymbalta (duloxetine) | ||||||||
Ratings & Reviews | |||||||||
Niacin has an average rating of 7.4 out of 10 from a total of 117 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 20% reported a negative effect. |
Cymbalta has an average rating of 6.3 out of 10 from a total of 1904 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Niacin side effects |
View all Cymbalta side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cymbalta prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
B-3-50, B3-500-Gr, Endur-acin, HDL Benefit, Heliocare Advanced, Niacin SR, Niacor, Niaspan, NiaVasc, Slo-Niacin, Vitamin B3 View more | Other duloxetine brands include: Drizalma Sprinkle, Irenka | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
1 hour |
17 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 107 drugs are known to interact with Niacin:
|
A total of 633 drugs are known to interact with Cymbalta:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
July 24, 1957 |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Lipitor
Lipitor is used to treat high cholesterol. Learn about side effects, interactions and indications.
Crestor
Crestor (rosuvastatin) is used to treat high cholesterol and high triglycerides in the blood ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zetia
Zetia (ezetimibe) is used to treat high cholesterol. Includes Zetia side effects, interactions and ...
Zocor
Zocor (simvastatin) reduces low-density lipoprotein cholesterol and total cholesterol in the blood ...
Mevacor
Mevacor is used for high cholesterol, high cholesterol, familial heterozygous ...
Colesevelam
Colesevelam is used for diarrhea, chronic, high cholesterol, hyperlipoproteinemia ...
Lovastatin
Lovastatin is used for high cholesterol, high cholesterol, familial heterozygous ...
Simvastatin
Simvastatin (Zocor) is a cholesterol-lowering medication that blocks the production of cholesterol ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.